MiR-411 regulated ITCH expression and promoted cell proliferation in human hepatocellular carcinoma cells

Biomedicine and Pharmacotherapy

Volumn 70, Issue C, 2015, Pages 158-163

  Xia, Kunkun ^a   Zhang, Yi ^a   Cao, Shengli ^a   Wu, Yang ^a   Guo, Wenzhi ^a   Yuan, Weitang ^a   Zhang, Shuijun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cell proliferation; Human hepatocellular carcinoma; ITCH; MiR 411

Indexed keywords

ITCH PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 411; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ITCH PROTEIN, HUMAN; MIRN411 MICRORNA, HUMAN; REPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

3' UNTRANSLATED REGION; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BIOINFORMATICS; CANCER INHIBITION; CANCER TISSUE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE REPRESSION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LUCIFERASE ASSAY; PRIORITY JOURNAL; PROTEIN RNA BINDING; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; UPREGULATION; BIOSYNTHESIS; HEPG2 CELL LINE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS; REPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84927556557     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.01.001     Document Type: Article

References (23)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., et al. Global cancer statistics. Cancer J Clin 2011, 61:69-90.
2. Wang Y., Luo Q., Li Y., Wang H., Deng S., et al. Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancer. PloS One 2014, 9:e103939.
3. Chen J., Gao J. Advances in the study of molecularly targeted agents to treat hepatocellular carcinoma. Drug Discov Ther 2014, 8:154-164.
4. Liccioni A., Reig M., Bruix J. Treatment of hepatocellular carcinoma. Dig Dis 2014, 32:554-563.
5. Honda Y., Kimura T., Aikata H., Nakahara T., Naeshiro N., et al. Pilot study of stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma. Hepatogastroenterology 2014, 61:31-36.
6. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., et al. The impact of micrornas on protein output. Nature 2008, 455:64-71.
7. Bartel D.P. Micrornas: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
8. Miska E.A. How micrornas control cell division, differentiation and death. Curr Opin Gen Dev 2005, 15:563-568.
9. Phuah N.H., Nagoor N.H. Regulation of micrornas by natural agents: new strategies in cancer therapies. Biomed Res Int 2014, 2014:804510.
10. Ambros V. The functions of animal micrornas. Nature 2004, 431:350-355.
11. Hu C.B., Li Q.L., Hu J.F., Zhang Q., Xie J.P., et al. Mir-124 inhibits growth and invasion of gastric cancer by targeting rock1. Asian Pac J Cancer Prev 2014, 15:6543-6546.
12. Tang J., Tao Z.H., Wen D., Wan J.L., Liu D.L., et al. Mir-612 suppresses the stemness of liver cancer via wnt/beta-catenin signaling. Biochem Biophys Res Commun 2014, 447:210-215.
13. Zhang Y., Zheng D., Xiong Y., Xue C., Chen G., et al. Mir-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating lrp6 post-transcriptionally. FEBS Lett 2014, 588:1913-1920.
14. Formosa A., Markert E.K., Lena A.M., Italiano D., Finazzi-Agro E., et al. Micrornas, mir-154, mir-299-5p, mir-376a, mir-376c, mir-377, mir-381, mir-487b, mir-485-3p, mir-495 and mir-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene 2013, 33:5173-5182.
15. Lehmann U., Streichert T., Otto B., Albat C., Hasemeier B., et al. Identification of differentially expressed micrornas in human male breast cancer. BMC Cancer 2010, 10:109.
16. Ho K.C., Zhou Z., She Y.M., Chun A., Cyr T.D., et al. Itch e3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected]. Proc Natl Acad Sci USA 2011, 108:4870-4875.
17. Salah Z., Melino G., Aqeilan R.I. Negative regulation of the hippo pathway by e3 ubiquitin ligase itch is sufficient to promote tumorigenicity. Cancer Res 2011, 71:2010-2020.
18. Ishihara T., Tsuda H., Hotta A., Kozaki K., Yoshida A., et al. Itch is a putative target for a novel 20q11.22 amplification detected in anaplastic thyroid carcinoma cells by array-based comparative genomic hybridization. Cancer Sci 2008, 99:1940-1949.
19. Sharma M., Sharma S., Arora M., Kaul D. Regulation of cellular cyclin d1 gene by arsenic is mediated through mir-2909. Gene 2013, 522:60-64.
20. Ratschiller D., Heighway J., Gugger M., Kappeler A., Pirnia F., et al. Cyclin d1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol 2003, 21:2085-2093.
21. Xu C., Wu C., Xia Y., Zhong Z., Liu X., et al. Wt1 promotes cell proliferation in non-small cell lung cancer cell lines through up-regulating cyclin d1 and p-prb in vitro and in vivo. PloS One 2013, 8:e68837.
22. Arici D.S., Tuncer E., Ozer H., Simek G., Koyuncu A. Expression of retinoblastoma and cyclin d1 in gastric carcinoma. Neoplasma 2009, 56:63-67.
23. Brychtova S., Brychta T., Sedlakova E., Kolar Z. Proto-oncogene c-myc in uterine cervix carcinogenesis. Neoplasma 2004, 51:84-89.